ExonHit, bioMérieux to discontinue colon cancer programme
Wednesday, March 10, 2010 16:00 IST Paris, France
ExonHit Therapeutics and bioMérieux have decided not to pursue their collaboration in colon cancer, following a recent review of data by their scientific committee.